Antares Pharma Inc. (ATRS) has declined -2.68% and closed its last trading session at $2.9.

Insider Trading

Insider Trading is buying and selling of a security by a person who has access to material information related to a security that is not available to general public. It can be both illegal and legal. For instance, insider trading is illicit when the trader has special information, which is not available to other shareholders.

“Senior Vice President & CFO at Antares Pharma Inc., Powell Fred M on 2017-06-09 Buy 130000 shares of the company at a price of $2.79. Similarly, the company’s President & CEO APPLE ROBERT F on 2017-04-05 Sell 40000 shares of the company at a price of $3.”

Now we will discuss the financial strength of Antares Pharma Inc.. The company’s average Piotroski F-Score: 3 during the last 7 years. Its mean Altman Z-Score: 7.29 during the last 7 years, while average Beneish M-Score: -2.87 during the last 7 years.

Revenue growth shows increase or decrease in sales over time. It is used to find out how fast a business is expanding. The average revenue per share growth rate of Antares Pharma Inc. during the past 12 months was 2.1 percent.

EBITDA margin is an indicator of a company’s operating profitability as a percentage of its overall revenue. It is equal to earnings before interest, tax, depreciation and amortization (EBITDA) divided by overall revenue. Antares Pharma Inc.’s average EBITDA per Share Growth Rate was 0 percent during the past 12 months.

The Relative Strength Index (RSI), developed by J. Welles Wilder, is a momentum oscillator that calculates the speed and change of price movements. The RSI oscillates between zero and 100. Relative Strength Index (RSI-14) for Antares Pharma Inc. (ATRS) is at 58.86.

The market capitalization of Antares Pharma Inc. is at $452.23 Million. The company has a Beta Value of 0.47. The YTD performance of the stock stands at 24.46 Percent. The Weekly and Monthly Volatility of the stock are 5.17% percent and 5.75% percent, respectively.

The SMA20 for the stock is at 10.14 percent, SMA50 stands at 4.43 percent, while SMA200 is 29.58 Percent.